SirPlux Duo Receives Breakthrough Designation

SirPlux Duo Receives Breakthrough Designation On May 28, 2021, the US Food and Drug Administration (FDA) granted Advanced NanoTherapies Breakthrough Designation for its SirPlux Duo device. SirPlux Duo is a drug-coated balloon (DCB) that leverages nanotechnology to...